Meeting
2016 ASCO Annual Meeting
Clinical genomic testing of anaplastic thyroid carcinoma (ATC) and need for integration into future prospective clinical trials.
Authors
Vlad Sandulache
Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX
Vlad Sandulache , Michelle D. Williams , Stephen Yenzen Lai , Charles Lu , William N. William Jr., Naifa Lamki Busaidy , Maria E. Cabanillas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Other Head and Neck Cancer (Salivary, Thyroid)
Citation
J Clin Oncol 34, 2016 (suppl; abstr 6085)
DOI
10.1200/JCO.2016.34.15_suppl.6085
Abstract #
6085
Poster Bd #
407
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
Poster
2016 ASCO Annual Meeting
Comprehensive Genomic sequencing (CGS) of 90 patient samples of anaplastic thyroid cancer (ATC).
First Author: Saad A. Khan